This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
5 Low Leverage Stocks to Buy Buoyed by Optimistic Economic Data
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You can buy DCI, ATR, LWAY, HWKN and STNG.
Greif (GEF) Completes Ipackchem Acquisition, Boosts Portfolio
by Zacks Equity Research
Greif (GEF) completes the acquisition of Ipackchem, which is expected to be immediately accretive to EBITDA margins.
Graphic Packaging (GPK) Up 15.7% in 3 Months: More Room to Run?
by Zacks Equity Research
Graphic Packaging (GPK) is well-poised to gain on rising demand for sustainable packaging options and a solid innovation pipeline.
Here's Why AptarGroup (ATR) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why AptarGroup (ATR) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Has AptarGroup (ATR) Outpaced Other Industrial Products Stocks This Year?
by Zacks Equity Research
Here is how AptarGroup (ATR) and Donaldson (DCI) have performed compared to their sector so far this year.
Is ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for REGL
Zacks Industry Outlook Highlights Packaging, AptarGroup and Greif.
by Zacks Equity Research
Packaging, AptarGroup and Greif are part of the Zacks Industry Outlook article.
3 Stocks to Watch in the Thriving Paper & Plastic Packaging Industry
by Madhurima Das
Strong demand for consumer-centric products and flourishing e-commerce activities will benefit companies like PKG, ATR and GEF, which belong to the Zacks Containers-Paper and Packaging industry.
5 Low Leverage Stocks to Buy With CPI Data Expected to Show Hike
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You can buy FRPT, ATR, MFC, HWKN and COLD.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AptarGroup, Inc. (ATR) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
AptarGroup (ATR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why AptarGroup (ATR) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are Industrial Products Stocks Lagging AptarGroup (ATR) This Year?
by Zacks Equity Research
Here is how AptarGroup (ATR) and DISCO CORP (DSCSY) have performed compared to their sector so far this year.
Here's Why AptarGroup (ATR) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AptarGroup (ATR) Scales 52-Week High: More Room to Run?
by Zacks Equity Research
AptarGroup (ATR) shares gain on better-than-expected Q4 results and an upbeat outlook for 2024. Ongoing momentum in the Pharma segment and focus on cost management will continue to drive results.
AptarGroup (ATR) Inks Deal to Create Digital Health Solutions
by Zacks Equity Research
AptarGroup (ATR) enters an enterprise agreement with Biogen to create digital health solutions for neurological and rare diseases.
Why AptarGroup (ATR) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is AptarGroup (ATR) Stock Outpacing Its Industrial Products Peers This Year?
by Zacks Equity Research
Here is how AptarGroup (ATR) and DISCO CORP (DSCSY) have performed compared to their sector so far this year.
AptarGroup, Inc. (ATR) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
AptarGroup (ATR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AptarGroup (ATR) Q4 Earnings Top Estimates, Revenues Rise Y/Y
by Zacks Equity Research
AptarGroup's (ATR) 2023 top line rises y/y on a favorable product mix, volume growth and pricing.
AptarGroup (ATR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for REGL
Why AptarGroup (ATR) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.